Madden Martin J. 4

What Happened

• Martin J. Madden, a director of Microbot Medical, was granted 10,000 shares on April 1, 2026. The shares were reported as acquired at $0.00 per share (total reported value $0), recorded on the Form 4 as a derivative award (transaction code A).
• This was an equity award (not an open-market purchase or sale), which is typically issued as director compensation or a restricted/RSU-type grant. The filing shows no proceeds or sale proceeds associated with the transaction.

Key Details

• Transaction date: 2026-04-01; Form 4 filed: 2026-04-03.
• Transaction type/code: Award/Grant (A) of 10,000 shares at $0.00 per share (total $0 reported).
• Shares owned after transaction: not specified in the disclosed transaction details.
• Vesting/restrictions: the filing does not specify vesting schedule or transfer restrictions.
• Timeliness: Filed two calendar days after the reported transaction (appears timely under the two-business-day Form 4 rule).

Context

• Awards reported at $0 typically represent restricted stock or RSUs granted as compensation rather than market purchases; they do not reflect an out-of-pocket purchase by the insider.
• Such grants are common for directors and do not necessarily signal a change in the insider’s market view; they mostly reflect compensation or retention arrangements.